Date | Dividends Paid | Capital Expenditure | Other Financing Activities | Net Cash Used Provided By Financing Activities |
---|
CEO | Mr. Matthew G. Sassone |
IPO Date | June 1, 2005 |
Location | United Kingdom |
Headquarters | Lynx Business Park |
Employees | 250 |
Sector | Health Care |
Industries |
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand. Tristel plc was founded in 1993 and is headquartered in Snailwell, the United Kingdom.
Past 5 years
USD 2.14
USD 25.51
USD 39.06
USD 2.66
USD 5.13
StockViz Staff
January 15, 2025
Any question? Send us an email